Pharvaris N.V.
PHVS$1.67B
Small CapNASDAQBiotechnology🇺🇸North America118 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Aug 15, 2026
22wMarket Overview
Stock performance and key metrics
PHVS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Deucrictibant | Phase 3 | Hereditary Angioedema | - | - |
Deucrictibant low dose | Phase 2 | Hereditary Angioedema | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply